🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Related News

Pristyn Care opens its first super-speciality hospital in South Delhi

EntrackrEntrackr · 1y ago
Pristyn Care opens its first super-speciality hospital in South Delhi
Medial

Pristyn Care opens its first super-speciality hospital in South Delhi Surgery-focused healthcare institution Pristyn Care has opened its first super-specialty hospital in South Delhi. With this, the Gurugram-based firm is expanding its infrastructure and deepening its commitment to advanced patient care. According to the company, the new hospital has four modular operating theaters with advanced technology, including a Level 3 NICU for newborn care. With the expansion, Pristyn Care is equipped to handle cosmetology and dermatology, offering a high-end setup for procedures such as anti-aging treatments, fat loss therapies, and CoolSculpting, along with a comprehensive range of laser treatments. In the last five years, Pristyn Care has conducted 300,000 surgeries. It now handles over 3 million patient interactions yearly, with 100,000 surgery registrations each month. Pristyn Care aims to establish 50 hospitals across 25 cities within the next three years, with plans to open 15 new hospitals in the coming year. The expansion will focus on key cities such as Delhi NCR, Bangalore, Hyderabad, Mumbai, Pune, Chennai, Patna, Coimbatore, Bhubaneswar, Chandigarh, Ahmedabad, and Kochi. Additionally, three new hospitals are set to be launched within the next four months. To support the growth, Pristyn Care aims to employ more than 3,500 healthcare professionals and 750 surgeons in the facilities. For the fiscal year ending in March 2024 (FY24), Pristyn Care’s operating revenue grew by 32.7% to Rs 601 crore from Rs 453 crore in FY23. In FY25, the company claims to have reduced its EBITDA burn by 60% year-over-year. In December 2021, the company secured $96 million from Peak XV Partners and Tiger Global to attain unicorn status.

USV acquires 79% stake in Wellbeing Nutrition at Rs 1,583 Cr valuation

EntrackrEntrackr · 13d ago
USV acquires 79% stake in Wellbeing Nutrition at Rs 1,583 Cr valuation
Medial

USV acquires 79% stake in Wellbeing Nutrition at Rs 1,583 Cr valuation Pharmaceutical major USV has signed a definitive agreement to acquire a 79% stake in Nutritionalab Private Limited, the parent company of Wellbeing Nutrition, to enter India’s fast-growing direct-to-consumer nutraceutical and wellness market. The transaction values Wellbeing Nutrition at around Rs 1,583 crore. Founded in 2019, Wellbeing Nutrition operates in the nutraceutical segment with a product portfolio that includes vitamins, minerals, protein, collagen, omega supplements and other wellness products. The company sells through its own digital platform, online marketplaces and offline retail channels, and has a presence in international markets including the US, UK and UAE. Wellbeing Nutrition claimed revenue of around Rs 170 crore in FY25, with a loss of around Rs 30 crore. According to the company, it has recorded 120% growth over the past two years and is targeting revenue of over Rs 450 crore by FY27. According to startup data platform TheKredible, Wellbeing Nutrition has raised close to $14 million to date, including a $10 million Series B round led by Fireside Ventures and Hindustan Unilever (HUL) in December 2022. As part of the transaction, existing investors are set to exit partially or fully. HUL will sell its entire 19.8% stake to USV for about Rs 307 crore. HUL had invested around Rs 70 crore in Wellbeing Nutrition, and the exit translates into more than four times return on its original investment. Fireside Ventures and other early investors are also expected to dilute their holdings. USV has a six-decade presence in the Indian pharmaceutical market and is a leader in oral anti-diabetic and cardiovascular therapies, with brands such as Glycomet GP, Ecosprin and Roseday. The company is also the exclusive partner for Sebamed in India. With this acquisition, USV is expanding its portfolio beyond prescription medicines into preventive and lifestyle-focused wellness. This is the second major acquisition in India’s D2C space in 2026. Last week, Mumbai-based consumer goods major Marico acquired a 60% stake in plant-based protein startup Cosmix at an equity valuation of Rs 375 crore. The move comes amid a broader FMCG consolidation trend, following Hindustan Unilever Limited’s acquisition of skincare brand Minimalist last year at a pre-money valuation of Rs 2,955 crore.

Download the medial app to read full posts, comements and news.